Aberrant increases in the level of anti-apoptotic Bcl-2 proteins such as BCL-2, MCL-1 or BCL-XL prevents apoptosis, this both promotes cancer and allows resistance to cancer therapy-induced cell killing3. Here, BCL2 is linked to cancer.